期刊文献+

女性甲状腺功能亢进症患者的骨密度变化 被引量:12

Change in bone mineral density in female patients with hyperthyroidism
下载PDF
导出
摘要 目的:观察女性甲状腺功能亢进症(甲亢)患者病程及绝经与否对骨密度的影响。方法:采用双能X线骨密度仪测定192例女性甲亢患者腰椎和髋部骨密度,分为绝经前和绝经后两组,按病程长短又分为短程和长程两亚组,并对两组测量结果进行分析。结果:绝经前甲亢病程长者L2及腰椎总体骨密度明显低于病程短者(P<0.05)。绝经后甲亢长程组腰椎及髋部各个测量部位的骨密度较短程者显著降低(P<0.05),在L2及髋部其差别尤其显著(P<0.01)。结论:病程及绝经与否影响着女性甲亢患者的骨密度。 Objective To investigate the effect of the course and menopause on the change of bone mineral density (BMD) in female patients with hyperthyroidism. Methods BMDs of hip and lumbar vertebrae were measured by dual-energy X-rays absorptiometry (DEXA) in the female patients ( n = 19 2, aged 14 - 7 2 ). Patients were divided into 2 groups ( premenopausal and postmenopausal ) and 2 subgroups( short-course and long-course). The BMDs were compared between those of agematched, weight-matched, height-matched and body mass index matched control subgroups. Results In the premenopausal hyperthyroidic patients, only the BMDs of the second and total lumbar vertebrae with longcourse were significantly lower than those of shortcourse group ( P 〈 0. 05 ). In the postmenopausal group with the long-course, each BMD measured had a lower level compared with that with short-course, of which the hip and the second lumber vertebrae were evident ( P 〈 0. 01 ). Conclusion The course and menopause have an effect on the BMDs in female patients with hyperthyroidism.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2008年第5期452-455,共4页 Journal of Central South University :Medical Science
关键词 甲状腺功能亢进症 骨密度 女性 双能X线骨密度测定 hyperthyroidism bone mineral density female dual-energy X-rays absorptiometry
  • 相关文献

参考文献10

  • 1徐浩,EichS.,H.甲亢患者骨密度和血清骨代谢指标的变化[J].中华内分泌代谢杂志,1998,14(4):244-247. 被引量:29
  • 2巴俊强,陈登科.性别与年龄对甲亢患者骨密度改变的影响[J].遵义医学院学报,2000,23(4):370-372. 被引量:2
  • 3Tauchmanova L, Nuzzo V, Del Puente A, et al. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre-and postmenopausal women with endogenous subclinical hyperthyroidism [ J ]. Maturitas, 2004,48 ( 3 ) :299-306.
  • 4Quan M L, Pasieka J L, Rorstad O. Bone mineral density in well-differentiated thyroid cancer patints treated with suppressive thyroxine : a systematic overview of the literature [ J ]. J Surg Oncol,2002,79( 1 ) : 62-69.
  • 5Reverter J L, Holgado S, Alonso N, et al. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma [ J ] . Endocr Relat Cancer,2005,12(4) :973-981.
  • 6Lee M S, Kim S X, Lee M C, et al. Negative correlation between the change in bone mineral density and osteocalcin in patients with hyperthyroidism [ J ]. J Clin Endocfin Metab, 1990,70(3) :766-770.
  • 7程梅芬,杨秀芳,朱禧星,王洪复.Graves病中某些骨代谢指标的测定[J].中华内分泌代谢杂志,1990,6(3):160-162. 被引量:11
  • 8Ben-Shlomo A, Hagag P, Evans S, et al. Early postmenopausal bone loss in hyperthyroidism [ J ] . Maturitas, 2001 , 39 (1) :19-27.
  • 9Mysliwiec J, Zbucki R, Winnicka M M, et al. A crucial role of interleukin-6 in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in mice [ J ] . Horm Metab Res,2007,39(12) :884-888.
  • 10梁晓萍,文锦丽,周文英,钟紫茹,周雅莹.甲亢患者骨密度、骨代谢指标及维生素D受体的变化[J].中华内分泌代谢杂志,2004,20(2):127-128. 被引量:29

二级参考文献10

共引文献61

同被引文献113

引证文献12

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部